Policy & Regulation
Johnson & Johnson launches new J&J Satellite Center for Global Health Discovery at Singapore's Duke-NUS Medical School
21 June 2022 -

United States-based Johnson & Johnson (NYSE: JNJ) announced on Monday that it has launched the new J&J Satellite Center for Global Health Discovery at Singapore's Duke-NUS Medical School, jointly set up by Duke University and the National University of Singapore (NUS) as a graduate-entry medical school and research powerhouse.

The Satellite Center at Duke-NUS intends to launch new solutions to address flaviviruses like dengue and Zika, which disproportionately affect communities across the region.

Professor Subhash Vasudevan, Ph.D., Duke-NUS' EID Program, and Olivia Goethals, Ph.D., principal scientist, Global Public Health R&D, Janssen Pharmaceutica NV are to head research at the Satellite Center at Duke-NUS.

Login
Username:

Password:


Related Headlines